The Evaluation of a Nasal Mask for the Treatment of Obstructive Sleep Apnea

The Evaluation of a Nasal Mask for the Treatment of Obstructive Sleep Apnea

This investigation is designed to evaluate the performance as well as the patients overall acceptance of the mask.

A maximum of 12 OSA participants who currently use a nasal mask will be recruited for the trial. Participant will be on the trial for 1 night (in-lab)

Inclusion Criteria:

• Adult (18+ years of age)
• Able to give consent
• Apnea hypopnea Index (AHI)≥ 5 on diagnostic night
• Prescribed PAP for OSA
• Existing nasal mask user

Exclusion Criteria:

• Inability to give consent
• Patients who are in a coma or a decreased level of consciousness
• Anatomical or physiological conditions making automatic positive airway pressure (APAP) therapy inappropriate (e.g. unconsolidated facial structure)
• Commercial drivers who are investigated by New Zealand Transport Agency
• Current diagnosis of carbon dioxide (CO2) retention
• Pregnant or may think they are pregnant